Invitrogen Expects to Complete Financing Next Week to Help Fund ABI Acquisition | GenomeWeb
NEW YORK (GenomeWeb News) – Invitrogen said yesterday that it expects to complete within the next seven days a $2.65 billion bank facility to partially fund its roughly $6.7 billion acquisition of Applied Biosystems.
 
Invitrogen said that the facility, which is being underwritten by Bank of America, UBS, and Morgan Stanley, is “substantially oversubscribed.”
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.